Annual Cash & Cash Equivalents
$9.25 M
+$7.70 M+499.11%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual cash & cash equivalents is $9.25 million, with the most recent change of +$7.70 million (+499.11%) on December 31, 2023.
- During the last 3 years, CYTH annual cash & cash equivalents has fallen by -$3.60 million (-28.02%).
- CYTH annual cash & cash equivalents is now -44.34% below its all-time high of $16.61 million, reached on December 31, 2021.
Performance
CYTH Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$928.00 K
-$193.80 K-17.28%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly cash and cash equivalents is $928.00 thousand, with the most recent change of -$193.80 thousand (-17.28%) on September 30, 2024.
- Over the past year, CYTH quarterly cash and cash equivalents has dropped by -$8.32 million (-89.96%).
- CYTH quarterly cash and cash equivalents is now -94.41% below its all-time high of $16.61 million, reached on December 31, 2021.
Performance
CYTH Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CYTH Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +499.1% | -90.0% |
| 3 y3 years | -28.0% | -90.0% |
| 5 y5 years | +317.0% | -90.0% |
CYTH Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.3% | +499.1% | -94.4% | +10.3% |
| 5 y | 5-year | -44.3% | +499.1% | -94.4% | +10.3% |
| alltime | all time | -44.3% | >+9999.0% | -94.4% | >+9999.0% |
Cyclo Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $928.00 K(-17.3%) |
| Jun 2024 | - | $1.12 M(-62.5%) |
| Mar 2024 | - | $3.00 M(-67.6%) |
| Dec 2023 | $9.25 M(+499.1%) | $9.25 M(+413.2%) |
| Sep 2023 | - | $1.80 M(+114.1%) |
| Jun 2023 | - | $841.50 K(-8.1%) |
| Mar 2023 | - | $915.20 K(-40.7%) |
| Dec 2022 | $1.54 M(-90.7%) | $1.54 M(-64.0%) |
| Sep 2022 | - | $4.29 M(-42.4%) |
| Jun 2022 | - | $7.45 M(-36.8%) |
| Mar 2022 | - | $11.80 M(-29.0%) |
| Dec 2021 | $16.61 M(+29.3%) | $16.61 M(+96.8%) |
| Sep 2021 | - | $8.44 M(-26.4%) |
| Jun 2021 | - | $11.46 M(-26.1%) |
| Mar 2021 | - | $15.51 M(+20.7%) |
| Dec 2020 | $12.85 M(+361.5%) | $12.85 M(+474.1%) |
| Sep 2020 | - | $2.24 M(+121.9%) |
| Jun 2020 | - | $1.01 M(+8.0%) |
| Mar 2020 | - | $933.50 K(-66.5%) |
| Dec 2019 | $2.78 M(+25.5%) | $2.78 M(-44.3%) |
| Sep 2019 | - | $4.99 M(-24.4%) |
| Jun 2019 | - | $6.61 M(+492.6%) |
| Mar 2019 | - | $1.12 M(-49.7%) |
| Dec 2018 | $2.22 M(+74.5%) | $2.22 M(+97.6%) |
| Sep 2018 | - | $1.12 M(-27.2%) |
| Jun 2018 | - | $1.54 M(+152.8%) |
| Mar 2018 | - | $609.60 K(-52.0%) |
| Dec 2017 | $1.27 M(+32.4%) | $1.27 M(-5.3%) |
| Sep 2017 | - | $1.34 M(+0.9%) |
| Jun 2017 | - | $1.33 M(-18.8%) |
| Mar 2017 | - | $1.64 M(+70.6%) |
| Dec 2016 | $960.20 K(-47.9%) | $960.20 K(-24.4%) |
| Sep 2016 | - | $1.27 M(-40.5%) |
| Jun 2016 | - | $2.13 M(+97.7%) |
| Mar 2016 | - | $1.08 M(-41.4%) |
| Dec 2015 | $1.84 M(-22.6%) | $1.84 M(-32.8%) |
| Sep 2015 | - | $2.74 M(+92.2%) |
| Jun 2015 | - | $1.43 M(-22.8%) |
| Mar 2015 | - | $1.85 M(-22.4%) |
| Dec 2014 | $2.38 M(+786.4%) | $2.38 M(-13.2%) |
| Sep 2014 | - | $2.74 M(+84.0%) |
| Jun 2014 | - | $1.49 M(+70.9%) |
| Mar 2014 | - | $872.50 K(+225.0%) |
| Dec 2013 | $268.50 K(+1077.6%) | $268.50 K(-50.3%) |
| Sep 2013 | - | $539.90 K(+1.4%) |
| Jun 2013 | - | $532.50 K(+445.0%) |
| Mar 2013 | - | $97.70 K(+328.5%) |
| Dec 2012 | $22.80 K | $22.80 K(-73.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $85.10 K(+86.6%) |
| Jun 2012 | - | $45.60 K(+78.1%) |
| Mar 2012 | - | $25.60 K(-79.9%) |
| Dec 2011 | $127.10 K(+19.0%) | $127.10 K(+400.4%) |
| Sep 2011 | - | $25.40 K(-82.1%) |
| Jun 2011 | - | $141.90 K(-59.4%) |
| Mar 2011 | - | $349.10 K(+226.9%) |
| Dec 2010 | $106.80 K(-68.5%) | $106.80 K(+1100.0%) |
| Sep 2010 | - | $8900.00(-93.2%) |
| Jun 2010 | - | $131.50 K(-47.8%) |
| Mar 2010 | - | $251.90 K(-25.7%) |
| Dec 2009 | $338.90 K(+22.5%) | $338.90 K(+21.7%) |
| Sep 2009 | - | $278.50 K(+16.4%) |
| Jun 2009 | - | $239.30 K(-8.2%) |
| Mar 2009 | - | $260.60 K(-5.8%) |
| Dec 2008 | $276.70 K(+31.8%) | $276.70 K(+13.8%) |
| Sep 2008 | - | $243.10 K(+17.7%) |
| Jun 2008 | - | $206.60 K(-30.2%) |
| Mar 2008 | - | $295.80 K(+40.9%) |
| Dec 2007 | $210.00 K(+789.8%) | $210.00 K(+746.8%) |
| Sep 2007 | - | $24.80 K(-42.5%) |
| Jun 2007 | - | $43.10 K(+9.9%) |
| Mar 2007 | - | $39.20 K(+66.1%) |
| Dec 2006 | $23.60 K(-23.9%) | $23.60 K(+69.8%) |
| Sep 2006 | - | $13.90 K(-62.4%) |
| Jun 2006 | - | $37.00 K(+0.3%) |
| Mar 2006 | - | $36.90 K(+19.0%) |
| Dec 2005 | $31.00 K(-67.2%) | $31.00 K(-53.0%) |
| Sep 2005 | - | $65.90 K(+36.7%) |
| Jun 2005 | - | $48.20 K(-69.2%) |
| Mar 2005 | - | $156.70 K(+66.0%) |
| Dec 2004 | $94.40 K(+1110.3%) | $94.40 K(-6.2%) |
| Sep 2004 | - | $100.60 K(+75.6%) |
| Jun 2004 | - | $57.30 K(-46.1%) |
| Mar 2004 | - | $106.40 K(+1264.1%) |
| Dec 2003 | $7800.00(-83.1%) | $7800.00(-87.7%) |
| Sep 2003 | - | $63.40 K(+25.0%) |
| Jun 2003 | - | $50.70 K(+39.7%) |
| Mar 2003 | - | $36.30 K(-21.4%) |
| Dec 2002 | $46.20 K(+463.4%) | $46.20 K(-39.8%) |
| Sep 2002 | - | $76.70 K(+188.3%) |
| Jun 2002 | - | $26.60 K(-38.9%) |
| Mar 2002 | - | $43.50 K(+430.5%) |
| Dec 2001 | $8200.00(-50.9%) | $8200.00(+67.3%) |
| Sep 2001 | - | $4900.00(+716.7%) |
| Jun 2001 | - | $600.00(-94.7%) |
| Mar 2001 | - | $11.30 K(-32.3%) |
| Dec 2000 | $16.70 K | $16.70 K |
FAQ
- What is Cyclo Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual cash & cash equivalents year-on-year change?
- What is Cyclo Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Cyclo Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CYTH is $9.25 M
What is the all time high annual cash & cash equivalents for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual cash & cash equivalents is $16.61 M
What is Cyclo Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CYTH annual cash & cash equivalents has changed by +$7.70 M (+499.11%)
What is Cyclo Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CYTH is $928.00 K
What is the all time high quarterly cash and cash equivalents for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly cash and cash equivalents is $16.61 M
What is Cyclo Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CYTH quarterly cash and cash equivalents has changed by -$8.32 M (-89.96%)